Evidence map›Paper›PMID 34805808›Full record

ArticleEClinicalMedicine2021

Corrigendum to "Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial." [EClinicalMedicine 37 (2021) 100981].

Vinicius Fontanesi Blum, Sérgio Cimerman, James R Hunter, Paulo Tierno, Acioly Lacerda, Alexandre Soeiro, Florentino Cardoso, Nancy Cristina Bellei, Juliana Maricato, Nathalia Mantovani and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in EClinicalMedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Vinicius Fontanesi BlumFederal University of São Paulo, São Paulo, Brazil.
Sérgio CimermanInstituto de Infectologia Emilio Ribas, São Paulo, Brazil.
James R HunterFederal University of São Paulo, São Paulo, Brazil.
Paulo TiernoHospital Municipal Dr. Francisco Moran (Barueri).
Acioly LacerdaSPDM (Guarulhos).
Alexandre SoeiroINCOR and Beneficência Portuguesa, São Paulo, Brazil.
Florentino CardosoHospital Vera Cruz (Campinas).
Nancy Cristina BelleiFederal University of São Paulo, São Paulo, Brazil.
Juliana MaricatoFederal University of São Paulo, São Paulo, Brazil.
Nathalia MantovaniFederal University of São Paulo, São Paulo, Brazil.
Marcella VassaoFederal University of São Paulo, São Paulo, Brazil.
Danilo DiasFederal University of São Paulo, São Paulo, Brazil.
Juliana GalinskasFederal University of São Paulo, São Paulo, Brazil.
Luis Mário Ramos JaniniFederal University of São Paulo, São Paulo, Brazil.
Joanna Reis Santos-OliveiraInstituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro, IFRJ, Rio de Janeiro, Brasil.
Alda Maria Da-CruzInstituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil (Laboratório Interdisciplinar de Pesquisa Médicas, Instituto Oswaldo Cruz (FIOCRUZ).
Ricardo Sobhie DiazFederal University of São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.eclinm.2021.100981.].

Identifiers

PMID34805808
PMCPMC8590842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.